Table 2.
Efficacy outcomes of natalizumab- and placebo-treated patients in the modified intent-to-treat population at 90 days
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.